Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.007 AUD
−7.13 M AUD
453.26 K AUD
1.33 B
About RESPIRI LIMITED
Sector
Industry
CEO
Marjan Mikel
Website
Headquarters
Melbourne
Founded
1987
ISIN
AU000000RSH4
FIGI
BBG000BX65N1
Respiri Ltd. engages in research, development, and commercialization of medical devices and the production of mobile health applications for management of asthma and related chronic respiratory diseases. Its proprietary apps, software, and devices will help people monitor the symptoms of their conditions, increase their awareness of risk of attack, adhere to their medication plans, improve outcomes, and reduce healthcare expenditures. The firm operates through the Australia and Israel segments. The Australia segment includes research, development, and commercialization of medical devices, and the production of mobile health applications in Australia. The Israel segment refers to the research, development and, commercialization of medical devices, and the production of mobile health applications in Israel. The company was founded by Noam Gavriely in 1987 and is headquartered in Melbourne, Australia.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of RSH is 0.078 AUD — it has increased by 2.63% in the past 24 hours. Watch RESPIRI LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange RESPIRI LIMITED stocks are traded under the ticker RSH.
RSH stock hasn't changed in a week, the month change is a 1.30% rise, over the last year RESPIRI LIMITED has showed a 160.00% increase.
RSH stock is 5.41% volatile and has beta coefficient of 1.26. Track RESPIRI LIMITED stock price on the chart and check out the list of the most volatile stocks — is RESPIRI LIMITED there?
Today RESPIRI LIMITED has the market capitalization of 100.82 M, it has increased by 4.00% over the last week.
Yes, you can track RESPIRI LIMITED financials in yearly and quarterly reports right on TradingView.
RESPIRI LIMITED is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
RSH net income for the last half-year is −3.94 M AUD, while the previous report showed −3.19 M AUD of net income which accounts for −23.66% change. Track more RESPIRI LIMITED financial stats to get the full picture.
No, RSH doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, RSH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade RESPIRI LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So RESPIRI LIMITED technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating RESPIRI LIMITED stock shows the buy signal. See more of RESPIRI LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.